Chemcrux Enterprises [CHEMCRUX] vs Camlin Fine Sciences [CAMLINFINE] Detailed Stock Comparison
Chemcrux Enterprises
BSE
Loading...
Camlin Fine Sciences
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Chemcrux Enterprises wins in 10 metrics, Camlin Fine Sciences wins in 8 metrics, with 0 ties. Chemcrux Enterprises appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Chemcrux Enterprises | Camlin Fine Sciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 60.94 | 51.69 | Camlin Fine Sciences |
| Price-to-Book Ratio | 2.24 | 3.95 | Chemcrux Enterprises |
| Debt-to-Equity Ratio | 56.68 | 77.88 | Chemcrux Enterprises |
| PEG Ratio | -0.66 | -0.71 | Camlin Fine Sciences |
| EV/EBITDA | 23.32 | 23.44 | Chemcrux Enterprises |
| Profit Margin (TTM) | 3.99% | -6.73% | Chemcrux Enterprises |
| Operating Margin (TTM) | 2.72% | -0.95% | Chemcrux Enterprises |
| EBITDA Margin (TTM) | 2.72% | N/A | N/A |
| Return on Equity | 5.24% | -15.89% | Chemcrux Enterprises |
| Return on Assets (TTM) | 3.08% | -6.87% | Chemcrux Enterprises |
| Free Cash Flow (TTM) | $-8.03M | $-157.24M | Chemcrux Enterprises |
| Dividend Yield | 0.74% | N/A | N/A |
| 1-Year Return | -44.23% | 90.50% | Camlin Fine Sciences |
| Price-to-Sales Ratio (TTM) | 2.42 | 2.31 | Camlin Fine Sciences |
| Enterprise Value | $1.97B | $40.90B | Camlin Fine Sciences |
| EV/Revenue Ratio | 2.83 | 2.39 | Camlin Fine Sciences |
| Gross Profit Margin (TTM) | 51.66% | 44.07% | Chemcrux Enterprises |
| Revenue per Share (TTM) | $46 | $96 | Camlin Fine Sciences |
| Earnings per Share (Diluted) | $1.86 | $3.67 | Camlin Fine Sciences |
| Beta (Stock Volatility) | -0.33 | 0.33 | Chemcrux Enterprises |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Chemcrux Enterprises vs Camlin Fine Sciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Chemcrux Enterprises | 1.32% | 2.54% | -3.32% | -12.75% | -19.70% | -32.99% |
| Camlin Fine Sciences | 2.10% | -7.72% | -9.41% | -36.63% | 13.09% | 39.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Chemcrux Enterprises | -44.23% | -73.01% | -52.10% | 217.54% | 217.54% | 217.54% |
| Camlin Fine Sciences | 90.50% | 69.09% | 75.50% | 81.91% | 113.24% | 113.24% |
News Based Sentiment: Chemcrux Enterprises vs Camlin Fine Sciences
Chemcrux Enterprises
News based Sentiment: NEGATIVE
The month presented a clear conflict: operational improvements with the plant reopening were overshadowed by dramatically declining financial performance and a continuing bearish stock trend. The significant drops in income, profit, and EPS, combined with the long-term stock underperformance, create a concerning investment picture.
Camlin Fine Sciences
News based Sentiment: POSITIVE
Camlin Fine Sciences is making a significant strategic move with the Vinpai acquisition, which is expected to expand its market reach. The stock has also shown positive momentum, indicating investor confidence. However, Vinpai's current financial performance and the P/E ratio fluctuations warrant continued monitoring.
Performance & Financial Health Analysis: Chemcrux Enterprises vs Camlin Fine Sciences
| Metric | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.78B | ₹40.45B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,031 | 572,357 |
| 90 Day Avg. Volume | 5,115 | 428,912 |
| Last Close | ₹114.95 | ₹194.37 |
| 52 Week Range | ₹100.20 - ₹184.70 | ₹95.59 - ₹333.30 |
| % from 52W High | -37.76% | -41.68% |
| All-Time High | ₹501.10 (Aug 29, 2022) | ₹333.30 (Jun 26, 2025) |
| % from All-Time High | -77.06% | -41.68% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | 0.07% |
| Quarterly Earnings Growth | -0.93% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | -0.07% |
| Operating Margin (TTM) | 0.03% | -0.01% |
| Return on Equity (TTM) | 0.05% | -0.16% |
| Debt to Equity (MRQ) | 56.68 | 77.88 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹50.64 | ₹47.98 |
| Cash per Share (MRQ) | ₹13.55 | ₹7.56 |
| Operating Cash Flow (TTM) | ₹96.58M | ₹-1,435,453,000 |
| Levered Free Cash Flow (TTM) | ₹39.13M | ₹-1,390,459,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.74% | N/A |
| Last 12-Month Dividend | ₹1.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Chemcrux Enterprises vs Camlin Fine Sciences
| Metric | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 60.94 | 51.69 |
| Forward P/E | N/A | 17.13 |
| PEG Ratio | -0.66 | -0.71 |
| Price to Sales (TTM) | 2.42 | 2.31 |
| Price to Book (MRQ) | 2.24 | 3.95 |
| Market Capitalization | ||
| Market Capitalization | ₹1.78B | ₹40.45B |
| Enterprise Value | ₹1.97B | ₹40.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.83 | 2.39 |
| Enterprise to EBITDA | 23.32 | 23.44 |
| Risk & Other Metrics | ||
| Beta | -0.33 | 0.33 |
| Book Value per Share (MRQ) | ₹50.64 | ₹47.98 |
Financial Statements Comparison: Chemcrux Enterprises vs Camlin Fine Sciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Revenue/Sales | ₹165.04M | ₹4.24B |
| Cost of Goods Sold | ₹79.78M | ₹2.37B |
| Gross Profit | ₹85.25M | ₹1.87B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹4.48M | ₹21.09M |
| EBITDA | ₹20.66M | ₹275.58M |
| Pre-Tax Income | ₹309,000 | ₹-42.64M |
| Income Tax | ₹-617,000 | ₹-100,000 |
| Net Income (Profit) | ₹927,000 | ₹-106.81M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Cash & Equivalents | ₹10.16M | ₹1.04B |
| Total Current Assets | ₹463.25M | ₹11.83B |
| Total Current Liabilities | ₹200.42M | ₹8.46B |
| Long-Term Debt | ₹286.55M | ₹2.93B |
| Total Shareholders Equity | ₹746.23M | ₹8.75B |
| Retained Earnings | ₹579.19M | ₹996.35M |
| Property, Plant & Equipment | ₹21.28M | ₹35.37M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,031 | 572,357 |
| Average Daily Volume (90 Day) | 5,115 | 428,912 |
| Shares Outstanding | 14.81M | 187.92M |
| Float Shares | 3.72M | 82.57M |
| % Held by Insiders | 0.76% | 0.46% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Chemcrux Enterprises vs Camlin Fine Sciences
| Metric | CHEMCRUX | CAMLINFINE |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.74% | N/A |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.50% | N/A |
| 3-Year Total Dividends | ₹5.00 | ₹0.00 |
| Ex-Dividend Date | Sep 06, 2024 | N/A |